Sign Up to like & get
recommendations!
0
Published in 2019 at "Nature biomedical engineering"
DOI: 10.1038/s41551-019-0387-2
Abstract: Acute myelogenous leukaemia (AML) is associated with risk factors that are largely unknown and with a heterogeneous response to treatment. Here, we provide a comprehensive quantitative understanding of AML proteomic heterogeneities and hallmarks by using…
read more here.
Keywords:
myelogenous leukaemia;
heterogeneities hallmarks;
analysis;
leukaemia cell ... See more keywords